兴 柏 集 团

以专精特新企业建设为抓手 实施高质量发展战略

兴柏集团作为获得石家庄市2021年度主导产业专项资金奖补的企业之一，《石家庄日报》对我集团分公司河北兴柏农业科技有限公司负责人刘进峰进行了专访。在采访中，刘总对获得这次奖补，十分激动，同时对市委、市政府对我们企业发展的关注及大力支持表示衷心的感谢。

以下是此次报道全部内容:

Xingbai Group

Implementing high-quality development strategy with the construction of new, distinctive, specialized and sophisticated enterprise

Xingbai Group, as one of the companies that have won the 2021 leading industry special fund award in Shijiazhuang City, the Shijiazhuang Daily conducted an exclusive interview with Liu Jinfeng, the person in charge of Hebei Xingbai Agricultural Technology Co., Ltd., a branch of our group.

In the interview, Mr. Liu was quite excited about the award, and expressed his heartfelt thanks to the Municipal Government for their attention and support to our development.

Hebei Xingbai Agricultural Technology Co., Ltd. is located in Zhao County Economic Development Zone, its leading industry is biopharmaceuticals, with microbial fermentation technology as a breakthrough point, the layout of agricultural development in urgent need of green and efficient new formulations, new varieties, is the national key support for high-tech field of industry. Our representative product abamectin fermentation scale ranks among the forefront of the national production capacity, the industrial scale and technology level plays a leading role in the industry. We has three major R&D platforms (provincial enterprise technology center, academician workstation and key laboratory of abamectin biotechnology in Hebei Province), and two major product quality control centers (strain selection and breeding center, central laboratory).

In recent years, Our group has closely focused on biological fermentation technology, implemented diversified business strategies, strictly controlled product quality, focused on the supply of upstream and downstream products, and closely connected the industrial chain. It has obtained 2 leading scientific and technological achievements in China, 1 provincial and municipal scientific and technological progress award, 1 provincial scientific and technological invention award, and the scientific and technological project "Abamectin High-efficiency Microbial Synthesis and Biological Manufacturing" won the second prize of National Science and Technology Progress Award, applied for more than 30 national invention patents, owned 11 authorized patents for core inventions, registered more than 100 brand trademarks of international and domestic products, established a consistent intellectual property system and built a high-value patent pool.

Xingbai group plans to complete its listing on the main board of the Hong Kong Stock Exchange by the end of June 2023 and to be listed on the domestic domestic A-share by the end of June 2024.

Editor of this article: Kou Na